Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 90.36M P/E - EPS this Y - Ern Qtrly Grth -
Income -35.46M Forward P/E -3.55 EPS next Y 21.40% 50D Avg Chg -4.00%
Sales 745.56k PEG - EPS past 5Y - 200D Avg Chg -13.00%
Dividend N/A Price/Book 2.57 EPS next 5Y - 52W High Chg -59.00%
Recommedations 1.30 Quick Ratio 3.46 Shares Outstanding 231.70M 52W Low Chg 22.00%
Insider Own 4.35% ROA -28.12% Shares Float 227.46M Beta 0.91
Inst Own 7.93% ROE -68.84% Shares Shorted/Prior 3.12M/6.09M Price 0.39
Gross Margin - Profit Margin - Avg. Volume 966,958 Target Price 3.33
Oper. Margin -4,218.05% Earnings Date May 16 Volume 934,084 Change 0.03%
Palatin Technologies, Inc. News
07:45 AM Palatin Technologies, Inc. (PTN) Reports Q3 Loss, Misses Revenue Estimates
06:30 AM Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
05/16/22 PhaseBio Pharmaceuticals (PHAS) Reports Q1 Loss, Misses Revenue Estimates
05/12/22 Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Tops Revenue Estimates
05/12/22 Palatin Announces $15 Million Private Placement of Convertible Redeemable Preferred Stock
05/11/22 Palatin to Report Third Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on May 17, 2022
05/10/22 Intra-Cellular Therapies (ITCI) Reports Q1 Loss, Tops Revenue Estimates
05/09/22 Berkeley Lights, Inc. (BLI) Reports Q1 Loss, Lags Revenue Estimates
05/05/22 Curis (CRIS) Reports Q1 Loss, Misses Revenue Estimates
05/02/22 Palatin to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Conference
04/21/22 Palatin to Present at Eyecelerator @ American Society of Cataract and Refractive Surgery (ASCRS) 2022
04/13/22 Repare Therapeutics Inc. (RPTX) Stock Jumps 9.1%: Will It Continue to Soar?
03/03/22 Palatin Hosting Key Opinion Leader Webinar on Dry Eye Disease
02/15/22 Palatin Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
02/14/22 Palatin Technologies, Inc. (PTN) Reports Q2 Loss, Tops Revenue Estimates
02/10/22 Ultragenyx (RARE) Reports Q4 Loss, Lags Revenue Estimates
02/10/22 Palatin to Report Second Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on February 15, 2022
02/09/22 Palatin Technologies, Inc. (PTN) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
02/08/22 Rainey & Randall Investment Management Inc. ...

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.

PTN Chatroom

User Image GreenDay888 Posted - 1 hour ago

$PTN this is annoying, are we getting rich or not? LoL

User Image GutShotDraw Posted - 2 hours ago

$PTN Here is why the Reverse Split will happen. Retail investors don't get to vote as our shares are not preferred shares. Holders of the Series B Preferred Stock and Series C preferred stock are entitled to vote only on the reverse stock split and any adjournment of the meeting related to the reverse split. To the extent these shares of the Series B or Series C are converted to common shares are redeemed for debt, which is our expectation. The company will use such net proceeds for working capital and general corporate purposes.

User Image Arahad Posted - 2 hours ago

$PTN peloton?

User Image cctranscripts Posted - 3 hours ago

Reading justifications stated in $PTN call transcript http://www.conferencecalltranscripts.org/include?location=https://seekingalpha.com/article/4512590-palatin-technologies-inc-ptn-ceo-carl-spana-on-q3-2022-results-earnings-call-transcript?utm_source=conferencecalltranscripts.org

User Image STCKPRO Posted - 3 hours ago

$PTN NEW ARTICLE : Palatin Technologies, Inc. (PTN) CEO Carl Spana on Q3 2022 Results - Earnings Call Transcript https://www.stck.pro/news/PTN/27884907

User Image naseem123 Posted - 3 hours ago

$PTN Just read the earnings call transcript. Not a single question on vyleesi, maybe analysts have given up on this asset?

User Image Stock_Ops Posted - 4 hours ago

$PTN what a pos

User Image Muhley Posted - 5 hours ago

$PTN Great call imo.

User Image psdslr Posted - 5 hours ago

$PTN Mom, this damn ticker broke again

User Image Muhley Posted - 5 hours ago

$PTN looks like pantginis is sticking with his $5 target. Still haven't heard from John Newman in quite a while now...

User Image STCKPRO Posted - 6 hours ago

$PTN NEW ARTICLE : Analysts’ Top Healthcare Picks: Palatin Technologies (PTN), Avrobio (AVRO) https://www.stck.pro/news/PTN/27878417

User Image mikedeatworld Posted - 7 hours ago

$PTN They are simply looking to keep the company running until they can retire....shares and dilution fixes that.

User Image tickeron Posted - 7 hours ago

If you’re trading this week, Read This! $PTN Aroon Indicator entered a Downtrend. View odds of downtrend. https://srnk.us/go/3672118

User Image risenhoover Posted - 7 hours ago

Also, if you are new to $PTN here's a background article on Finpedia for you https://finpedia.co/bin/Palatin%20Technologies/

User Image risenhoover Posted - 7 hours ago

$PTN / Palatin Technologies files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported): May 17, 2022 https://fintel.io/sf/us/ptn?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

User Image Last10K Posted - 7 hours ago

$PTN just filed with the SEC a Earnings Release and a Financial Exhibit https://last10k.com/sec-filings/ptn/0001654954-22-007020.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ptn

User Image Zaleiko Posted - 7 hours ago

$PTN Ouch

User Image Bosoxpj Posted - 7 hours ago

$PTN not sure how the offering puts the company in “ excellent position to do a reverse split. Usually a company stock doing bad puts it in a position for a reverse split. Also should a company try to have the value and execution help “price common stock at a price per share reflective of the development stage of Palatin” not depend on r/s. They need to give an update on Vyleesi partnership or sale.

User Image cctranscripts Posted - 7 hours ago

Palatin Reports Third Quarter Fiscal Year 2022 Financial Results https://www.conferencecalltranscripts.com/summary/?id=10861582 $PTN

User Image Quantisnow Posted - 8 hours ago

$PTN 📜 Palatin Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits https://quantisnow.com/i/2900769?utm_source=stocktwits 45 seconds delayed.

User Image fla Posted - 8 hours ago

$PTN [15s. delayed] filed form 8-K on May 17, 08:46:06 https://s.flashalert.me/jyy41

User Image MarketNewswire Posted - 8 hours ago

$PTN New SEC Filing: 8-K Earnings - PALATIN TECHNOLOGIES INC (0000911216) May 17 Item 2.02 Results of Operations and Financial Condition. On May 17, 2022, we issued a press release including results for our third quarter ended March 31, 2022 and announcing a teleconference and webcast to be held May 17, 2022 at 11:00 a.m. Eastern time, which will include a discussion on results of operations in greater detail and an update on corporate developments. We have attached a copy of the press release as an exhibit to this report. The information in this Item 2.02 and the corresponding information in the attached Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of (...) https://marketnewswire.live?p=321495

User Image Newsfilter Posted - 8 hours ago

$PTN Form 8-K: Results of Operations and Financial Condition. On May 17, 2022, we issued a press release including results for our third quarter ended March 31, 2022 and announcing a teleconference an.. https://newsfilter.io/a/e1e98372d16024efa96fc5f368f14e56

User Image Darkwatcher Posted - 8 hours ago

$PTN 😁🤣😂🤣👏👏👏👏🤘➰

User Image stockilluminati Posted - 9 hours ago

$PTN https://www.stockilluminati.com/ptn/news.php - Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

User Image epsguid Posted - 9 hours ago

$PTN reported a loss of $0.03, consensus was ($0.03) via @eWhispers #epsmeet http://eps.sh/d/ptn

User Image STCKPRO Posted - 9 hours ago

$PTN NEW ARTICLE : Palatin Tech GAAP EPS of -$0.03 beats by $0.01, revenue of $0.22M misses by $1.12M https://www.stck.pro/news/PTN/27870104

User Image fla Posted - 9 hours ago

$PTN [15s. delayed]: Issued Press Release on May 17, 07:30:00: Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provid https://s.flashalert.me/zW21N

User Image Quantisnow Posted - 9 hours ago

$PTN 📰 Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update https://quantisnow.com/i/2899809?utm_source=stocktwits 45 seconds delayed.

User Image Stock_Titan Posted - 9 hours ago

$PTN Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update https://www.stocktitan.net/news/PTN/palatin-reports-third-quarter-fiscal-year-2022-financial-results-and-ioe9f4br1skd.html

Analyst Ratings
HC Wainwright & Co. Buy Nov 24, 21
Ladenburg Thalmann Buy Jun 27, 18
H.C. Wainwright Buy Apr 6, 18
Canaccord Genuity Buy Jun 5, 15
Canaccord Genuity Buy Mar 2, 15
PiperJaffray Overweight Jun 20, 13